The Open Press - Press Release News Wire
  Saturday, April 27th 2024 - 11:34pm EDT
PRESS RELEASE NEWS WIRE         
     FRONT PAGE     |     ARCHIVES     |     ABOUT US     |     FAQS      
Welcome Guest User  ( LOG IN )      SUBMIT A RELEASE   ADD A FIRM   
Sorting Options

By Country

By Metro Area

By Industry

Member Options


Register

Login

Recover Password

Email Alert
Site Navigation

Home

Services & Fees

Press Release Guidelines

Submit a Press Release

Company Directory

Contact Us

RSS Feeds

Help

|Press Releases|Pro PRs|Book Reviews|Articles (OP-ED)|News|Exposé|PR Firms|


Custom Synthesis Chemistry Services CRO, Onyx Scientific, Hails the Success of Solid-State Services

Submitted by: Liquid Lens Ltd

2010-12-29 00:09:57

del.icio.us digg facebook Email twitter print

Custom Synthesis chemistry services CRO, Onyx Scientific, hails the success of its solid-state polymorph screening services for increased process development and GMP synthesis demand. Onyx Scientific provides custom synthesis chemistry services throughout all stages of a drug-discovery process for phase l and ll clinical studies.

(OPENPRESS) December 29, 2010 -- Onyx Scientific, a trusted global chemistry services CRO and leading provider of high justified intermediates and APIs for both phase I and phase II clinical studies, hails the success of its world-class solid-state polymorph screening services for the increased demand for its international GMP-compliant Process Development capability.

Onyx Scientific specialise in Medicinal Chemistry, Process Development, Custom Synthesis, GMP synthesis and Scale-up, in addition to a comprehensive range of Analytical and Solid-State services including automated Salt Selection and Polymorphism studies, with the capability to deliver API scale-up to multi-kilo level and beyond.

CEO, Onyx scientific Ltd, Tony Flynn comments, "the genuine skills and experience required to develop sustainable Process Development are relatively rare. We routinely develop robust, safe and reproducible processes with an emphasis on compound quality, purity and pharmacological properties".

Tony adds, "our synthetic organic chemistry expertise and automated screening platform enable the rapid evaluation of possible solid-forms and polymorphs for maximum intellectual property generation. We constantly adapt our services to meet the needs of our pharmaceutical and biotech customers with a focus on building long-term customer relationships".

Recognised as the preferred contract research organisation to four of the world's top seven pharmaceutical companies, Onyx offers a unique and flexible chemistry outsourcing experience and enjoys repeat business with more than 150 companies worldwide.

Onyx Scientific is routinely inspected by the MHRA and holds a GMP Certificate for the development and manufacture of Active Pharmaceutical Ingredients (API's). The Onyx facilities, systems and activities comply with the Good Manufacturing Practice requirements referred to in Part II of the EU Guidelines to Good Manufacturing Practice.

www.onyx-scientific.com

Services include: Process Development, Custom Synthesis, GMP synthesis and Scale-up, in addition to a comprehensive range of Analytical and Solid-State services including automated Salt Selection and Polymorphism studies, with the capability to deliver API scale-up to multi-kilo level and beyond.




Contact Info

Liquid Lens Ltd
Phone: +44 (0) 1525 371371
Website: http://www.liquid-lens.com
Unit 4 Grovebury Place Estate
Grovebury Road
Leighton Buzzard
Bedfordshire
LU7 4SH
UK



Release Info

Metro Area: ALL REGIONS (Including International) Read More from this Metro Area
Country: United Kingdom Read more from this Country
Industry: Science Read more from this Industry
Press Keywords: custom synthesis,chemistry services,polymorph screening,salt selection,CRO
Press Company: Onyx Scientific Ltd
Press Site: http://www.onyx-scientific.com




 


Copyright © 2024
The Open Press - Professional Press Release News Wire.
All rights reserved.


   Home|About Us|Archives|Faqs|Services & Fees|Guidelines|Submit Release|Register|Privacy Policy|Contact Us|RSS Feeds|Email Alert